Phase II trials of malignant mesothelioma: a commentary and update.
Krarup-Hansen
A
A
Department of Oncology, Finsen Institute, University Hospital of Copenhagen, Rigshospitalet, Denmark.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic / Q000379:methods* / Q000592:standards; D006801:Humans; D008654:Mesothelioma / Q000188:drug therapy*; D013223:Statistics as Topic / Q000379:methods / Q000592:standards
D000970:Antineoplastic Agents